BOCCARELLI, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 4.717
AS - Asia 2.279
EU - Europa 2.060
SA - Sud America 681
AF - Africa 147
OC - Oceania 4
AN - Antartide 1
Totale 9.889
Nazione #
US - Stati Uniti d'America 4.645
SG - Singapore 879
RU - Federazione Russa 877
CN - Cina 620
BR - Brasile 537
SE - Svezia 289
HK - Hong Kong 231
IT - Italia 225
VN - Vietnam 165
DE - Germania 147
UA - Ucraina 117
FI - Finlandia 116
FR - Francia 105
CI - Costa d'Avorio 88
IN - India 76
GB - Regno Unito 72
BD - Bangladesh 56
AR - Argentina 54
ID - Indonesia 46
CA - Canada 27
IQ - Iraq 27
MX - Messico 27
EC - Ecuador 24
JP - Giappone 24
TR - Turchia 22
ZA - Sudafrica 20
PK - Pakistan 18
CO - Colombia 17
BE - Belgio 16
ES - Italia 16
PH - Filippine 15
VE - Venezuela 15
IE - Irlanda 14
NL - Olanda 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
JO - Giordania 12
PE - Perù 12
PL - Polonia 12
TN - Tunisia 10
CL - Cile 9
KE - Kenya 8
PY - Paraguay 7
AT - Austria 6
CZ - Repubblica Ceca 6
IL - Israele 6
KR - Corea 6
MY - Malesia 6
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
IR - Iran 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
OM - Oman 4
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
AQ - Antartide 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
QA - Qatar 1
SV - El Salvador 1
UY - Uruguay 1
Totale 9.889
Città #
Ashburn 468
Singapore 426
Fairfield 400
Woodbridge 375
Chandler 370
Jacksonville 262
Nyköping 242
San Jose 242
Hong Kong 229
Houston 210
Seattle 191
Cambridge 171
Ann Arbor 164
Wilmington 157
Beijing 149
Bari 124
Nanjing 101
New York 95
Abidjan 88
Lawrence 88
Roxbury 88
Lauterbourg 82
Ho Chi Minh City 67
Des Moines 60
Los Angeles 60
Boardman 56
Helsinki 53
Dallas 51
São Paulo 42
Princeton 38
Brooklyn 35
Council Bluffs 33
Inglewood 31
Santa Clara 29
Buffalo 28
Hanoi 27
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 25
Tokyo 24
San Diego 22
Munich 21
Jakarta 19
Jiaxing 19
Pune 18
Belo Horizonte 17
Brussels 15
San Francisco 15
Tianjin 15
Baghdad 14
Brasília 14
Moscow 14
Rio de Janeiro 14
Dublin 13
Guangzhou 13
Orem 13
Amman 12
Columbus 12
Falkenstein 12
The Dalles 12
Shanghai 11
Tashkent 11
Boston 10
Curitiba 10
Dhaka 10
Milan 10
Montreal 10
Porto Alegre 10
Amsterdam 9
Changsha 9
Chicago 9
Quito 9
Salvador 9
Chennai 8
Johannesburg 8
Lima 8
Nairobi 8
Nuremberg 8
Paris 8
Warsaw 8
Cape Town 7
Istanbul 7
Kunming 7
London 7
Ningbo 7
Phoenix 7
Poplar 7
Stockholm 7
Turku 7
Washington 7
Wuxi 7
Atlanta 6
Buenos Aires 6
Da Nang 6
Denver 6
Goiânia 6
Guayaquil 6
Hefei 6
Medellín 6
Totale 6.069
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 714
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 236
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 216
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 178
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 174
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 174
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 167
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 166
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 166
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 162
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 155
Endothelial cells in the bone marrow of patients with multiple myeloma 135
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 123
Antitumour platinum iminoether complexes 122
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 121
Antitumour ruthenium(II)-dimethylsulfoxide complexes 121
Platinum(II) based anticancer agents with a trans geometry 120
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 120
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 119
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 117
Antitumour platinum-iminoether complexes 112
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 112
Antitumour platinum iminoether complexes 112
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 112
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 111
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 109
Antitumor activity of trans platinum complexes 107
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 106
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 106
null 104
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 98
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 97
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 97
A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics 96
A second life for MAO inhibitors? From CNS diseases to anticancer therapy 96
Bone Marrow Fibroblasts and Multiple Myeloma Progression 95
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 94
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 94
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 93
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity 93
null 92
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 92
A trans-platinum complex showing higher antitumor activity than the cis congeners 92
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 91
Inhibition of matrix metallo proteinases activity by platinum complexes 90
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 90
Complessi antitumorali di platino a geometria trans 89
null 88
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 88
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 85
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 83
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 81
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 80
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 80
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 79
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 78
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 77
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 76
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 76
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 75
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 74
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 74
Screening tests for selecting anticancer metal compounds 73
A new generation of platinum anticancer complexes with trans geometry 73
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 72
Complessi antitumorali di platino a geometria trans 71
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 70
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 70
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 69
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 69
null 68
DNA interaction properties of platinum –iminoether complexes 67
null 67
null 66
null 65
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 65
null 65
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 64
Platinum(II) complexes with acyclovir: synthesis and biological activity 63
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 62
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 61
Complessi antimetastatici di rutenio 61
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 60
Interazione DNA-isomeri del [PtCl2(DACH)] 59
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 59
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 57
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 55
null 55
null 55
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 55
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 54
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 54
null 53
null 52
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 52
New platinum antitumor complexes with chiral diamines 51
null 51
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 50
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 50
Synthesis, Biophysical Studies, and Antiproliferative Activity of Platinum(II) Complexes Having 1,2-Bis(aminomethyl)carbobicyclic Ligands 47
Totale 9.790
Categoria #
all - tutte 37.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 0 0 0 0 0 109 74 33
2021/2022555 15 90 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024430 30 50 19 18 60 135 4 33 11 10 2 58
2024/20251.540 89 26 129 52 59 113 232 103 52 65 243 377
2025/20263.706 440 148 295 439 435 193 317 88 1.064 287 0 0
Totale 10.292